NASDAQ:OMDA Omada Health (OMDA) Stock Price, News & Analysis $18.61 +0.01 (+0.05%) As of 11:58 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Omada Health Stock (NASDAQ:OMDA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Omada Health alerts:Sign Up Key Stats Today's Range$18.41▼$18.7950-Day Range$12.46▼$18.5852-Week Range$10.28▼$26.92Volume121,239 shsAverage Volume1.19 million shsMarket Capitalization$1.11 billionP/E RatioN/ADividend YieldN/APrice Target$22.91Consensus RatingModerate Buy Company Overview Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching. In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management. The company integrates connected devices—such as smart scales, blood pressure monitors and activity trackers—to monitor participants’ progress and deliver real-time insights. Its multidisciplinary care teams, which include health coaches, registered dietitians and behavioral health specialists, work collaboratively to guide users toward sustainable lifestyle changes and clinical goals. Founded in 2011 and headquartered in San Francisco, Omada Health partners with a range of stakeholders including employers, health plans and healthcare systems across the United States. Through these partnerships, the company aims to reduce the incidence and costs of chronic disease while improving long-term health outcomes. Co-founder and CEO Sean Duffy leads the organization’s strategic vision, overseeing product development and market expansion initiatives.AI Generated. May Contain Errors. Read More Omada Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks48th Percentile Overall ScoreOMDA MarketRank™: Omada Health scored higher than 48% of companies evaluated by MarketBeat, and ranked 367th out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingOmada Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.69, and is based on no strong buy ratings, 10 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialOmada Health has a consensus price target of $22.91, representing about 23.9% upside from its current price of $18.48.Amount of Analyst CoverageOmada Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Omada Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Omada Health are expected to grow in the coming year, from ($0.01) to $0.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Omada Health is -68.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Omada Health is -68.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOmada Health has a P/B Ratio of 4.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.56% of the float of Omada Health has been sold short.Short Interest Ratio / Days to CoverOmada Health has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Omada Health has recently increased by 15.01%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOmada Health does not currently pay a dividend.Dividend GrowthOmada Health does not have a long track record of dividend growth. News and Social Media0.9 / 5News Sentiment-0.62 News SentimentOmada Health has a news sentiment score of -0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Omada Health this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for OMDA on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Omada Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $974,962.00 in company stock.Percentage Held by Insiders6.38% of the stock of Omada Health is held by insiders.Percentage Held by InstitutionsOmada Health has minimal institutional ownership at this time.Read more about Omada Health's insider trading history. Receive OMDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Omada Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OMDA Stock News HeadlinesOmada Health (NASDAQ:OMDA) CAO Craig Gracey Sells 2,083 Shares of StockJune 25 at 6:36 AM | insidertrades.comOmada Health (NASDAQ:OMDA) CEO Sells $259,705.60 in StockJune 21, 2026 | americanbankingnews.comThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.June 25 at 1:00 AM | American Alternative (Ad)Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells 14,960 Shares of StockJune 19, 2026 | insidertrades.comOmada Health (NASDAQ:OMDA) President Sells $79,114.36 in StockJune 17, 2026 | insidertrades.comOmada Health Shareholders Back Board and Auditor at MeetingJune 16, 2026 | tipranks.comOmada Health, Inc. (NASDAQ:OMDA) Given Average Rating of "Moderate Buy" by AnalystsJune 16, 2026 | americanbankingnews.comOmada Health to Participate in Goldman Sachs Global Healthcare ConferenceMay 27, 2026 | globenewswire.comSee More Headlines OMDA Stock Analysis - Frequently Asked Questions How have OMDA shares performed this year? Omada Health's stock was trading at $15.78 at the beginning of 2026. Since then, OMDA shares have increased by 17.1% and is now trading at $18.4840. How were Omada Health's earnings last quarter? Omada Health, Inc. (NASDAQ:OMDA) released its quarterly earnings results on Thursday, May, 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company earned $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative trailing twelve-month return on equity of 1.82%. Read the conference call transcript. When did Omada Health IPO? Omada Health (OMDA) raised $150 million in an initial public offering on Friday, June 6th 2025. The company issued 7,900,000 shares at a price of $18.00-$20.00 per share. Who are Omada Health's major shareholders? Top institutional investors of Omada Health include SG Americas Securities LLC (1.40%), Perceptive Advisors LLC (1.32%), Rock Springs Capital Management LP (0.91%) and Renaissance Technologies LLC (0.66%). Insiders that own company stock include Sean P Duffy, Wei-Li Shao, Steven L Cook and Craig Gracey. View institutional ownership trends. How do I buy shares of Omada Health? Shares of OMDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/07/2026Today6/25/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 For the last 2 weeks, OMDA's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:OMDA Previous SymbolNASDAQ:OMDA CIK1611115 WebN/A Phone(888) 987-8337FaxN/AEmployees849Year Founded2011Price Target and Rating Average Price Target for Omada Health$22.91 High Price Target$30.00 Low Price Target$18.00 Potential Upside/Downside+23.1%Consensus RatingModerate Buy Rating Score (0-4)2.69 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($0.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.78 million Net Margins-2.22% Pretax Margin-2.22% Return on Equity-1.82% Return on Assets-1.36% Debt Debt-to-Equity RatioN/A Current Ratio3.92 Quick Ratio3.87 Sales & Book Value Annual Sales$283.30 million Price / Sales3.91 Cash FlowN/A Price / Cash FlowN/A Book Value$3.97 per share Price / Book4.69Miscellaneous Outstanding Shares59,449,000Free Float55,656,000Market Cap$1.11 billion OptionableN/A BetaN/A Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:OMDA) was last updated on 6/25/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredSpaceX is offering you shares. Don't take them.SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...Behind the Markets | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omada Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omada Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
